Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹855.00
Market cap: ₹1,008 Cr
Revenue (annual): ₹853.6 Cr
Net profit (annual): ₹36.99 Cr
P/E (TTM): 27.2×Sector 47.4×
Promoter holding: 70.95%
FII holding: 5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Management Change 2 Financial Results 2 Dividend 2 SME to Main Board Migration 1 Results Update 1 Other Announcement 1 Merger & Restructuring 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

17 Apr 2026 18:18 IST NSE

Other Announcement

Remus Pharmaceuticals Other Announcement

Remus Pharmaceuticals Limited submitted its compliance certificate for the financial year ended March 31, 2026, regarding the maintenance of a Structured Digital Database. Issued by Practicing Company Secretary Tapan Shah, the certificate confirms the company has captured all six required events and maintained a non-tamperable audit trail in compliance with SEBI Insider Trading regulations.

Read the filing ↗